Type-specific evolution of amyloid plaque and angiopathy in APPsw mice

[1]  T. Tabira,et al.  Intracellular Aβ42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer's disease , 2005 .

[2]  C. Duyckaerts,et al.  Subcellular topography of neuronal Abeta peptide in APPxPS1 transgenic mice. , 2004, The American journal of pathology.

[3]  D. Dickson,et al.  Dimeric Amyloid β Protein Rapidly Accumulates in Lipid Rafts followed by Apolipoprotein E and Phosphorylated Tau Accumulation in the Tg2576 Mouse Model of Alzheimer's Disease , 2004, The Journal of Neuroscience.

[4]  Koji Abe,et al.  Amyloid cored plaques in Tg2576 transgenic mice are characterized by giant plaques, slightly activated microglia, and the lack of paired helical filament-typed, dystrophic neurites , 2002, Virchows Archiv.

[5]  Mikio Shoji,et al.  Age-Dependent Changes in Brain, CSF, and Plasma Amyloid β Protein in the Tg2576 Transgenic Mouse Model of Alzheimer's Disease , 2001, The Journal of Neuroscience.

[6]  Ruedi Aebersold,et al.  Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and βAPP processing , 2000, Nature.

[7]  D. Selkoe,et al.  The oligomerization of amyloid beta-protein begins intracellularly in cells derived from human brain. , 2000, Biochemistry.

[8]  S. Hirai,et al.  Age‐related amyloid β protein accumulation induces cellular death and macrophage activation in transgenic mice , 2000 .

[9]  A. Mochizuki,et al.  Aβ42-positive non-pyramidal neurons around amyloid plaques in Alzheimer's disease , 2000, The Lancet.

[10]  B. Sommer,et al.  Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Haruhisa Inoue,et al.  Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation , 1999, Nature Medicine.

[12]  Y. Ihara,et al.  The presence of amyloid beta-protein in the detergent-insoluble membrane compartment of human neuroblastoma cells. , 1998, Biochemistry.

[13]  D. Selkoe,et al.  The Proteolytic Fragments of the Alzheimer’s Disease-associated Presenilin-1 Form Heterodimers and Occur as a 100–150-kDa Molecular Mass Complex* , 1998, The Journal of Biological Chemistry.

[14]  B. Hyman,et al.  APPSW Transgenic Mice Develop Age‐related Aβ Deposits and Neuropil Abnormalities, but no Neuronal Loss in CA1 , 1997, Journal of neuropathology and experimental neurology.

[15]  Y. Ihara,et al.  Intracellular Generation and Accumulation of Amyloid β-Peptide Terminating at Amino Acid 42* , 1997, The Journal of Biological Chemistry.

[16]  S. Younkin,et al.  Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice , 1996, Science.

[17]  T. Iwatsubo,et al.  Amino- and carboxyl-terminal heterogeneity of β-amyloid peptides deposited in human brain , 1996, Neuroscience Letters.

[18]  S. Hirai,et al.  Intracellular generation of amyloid β protein from amyloid β protein precursor fragment by direct cleavage with β- and γ-secretase , 1996 .

[19]  S. Hirai,et al.  Amyloid β-protein ending at Thr43 is a minor component of some diffuse plaques in the Alzheimer's disease brain, but is not found in cerebrovascular amyloid , 1995, Brain Research.

[20]  S. Hirai,et al.  Modified Amyloid β Protein Ending at 42 or 40 with Different Solubility Accumulates in the Brain of Alzheimer′s Disease , 1995 .

[21]  D. Mann,et al.  Amyloid β protein (Aβ) deposition: Aβ42(43) precedes Aβ40 in down Syndrome , 1995, Annals of neurology.

[22]  L. Mucke,et al.  Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein , 1995, Nature.

[23]  T. Iwatsubo,et al.  Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43) , 1994, Neuron.

[24]  Y. Ihara,et al.  Spatial resolution of the primary beta-amyloidogenic process induced in postischemic hippocampus. , 1994, The Journal of biological chemistry.

[25]  S. Estus,et al.  Production of the Alzheimer amyloid beta protein by normal proteolytic processing. , 1992, Science.

[26]  M. Katsuki,et al.  Hepatic and renal expression of rat apolipoprotein E under control of the metallothionein promotor in transgenic mice , 1991 .

[27]  D. Mann,et al.  The pattern of acquisition of plaques and tangles in the brains of patients under 50 years of age with Down's syndrome , 1989, Journal of the Neurological Sciences.

[28]  S. Hirai,et al.  A variety of cerebral amyloid deposits in the brains of the Alzheimer-type dementia demonstrated byβ protein immunostaining , 2004, Acta Neuropathologica.

[29]  P. Greengard,et al.  Intraneuronal Aβ42 Accumulation in Human Brain , 2000 .